Back to Directory
research logo

Guardant Health | Company Profile

11/26/2025

Contact Information

👤
Guardant Health
🏢
Guardant Health
📍
3100 Hanover Street, Palo Alto, California 94304, US

Industry & Market

Primary Industry
research
Location
Palo Alto, California, United States
Public Trading
NASDAQ: GH

Company Metrics

👥Total Employees
1,132
⚙️Engineering
281
💼Sales Team
481
📈Marketing
31
📅Founded
2012
💰Revenue
739M

Funding Information

Market Cap
$12.2B
Annual Revenue
$739,016,000
Publicly traded company

Headcount Distribution

Total Employees
1,132
Departments
19

By Department

Department Breakdown

Sales
Engineering
Operations
Business Development
Human Resources
Marketing
Others

Technology Stack

Analytics & Tracking

Facebook Conversion TrackingGoogle AnalyticsGoogle Tag Manager

Social & Marketing

Facebook Conversion TrackingLinkedin Marketing Solutions

Video & Media

VimeoYouTube

Email & Communication

Outlook
Total: 28 technologies

Keywords & Focus Areas

health & wellnessmedical specialitieshealth carebiotechnology researchearly detectionpharmaceuticalscancer treatment response monitoringhealthcarecancer recurrence detectionmolecular profilingclinical oncologycirculating tumor dna diagnosticscancer managementcancer treatment personalizationfda-approved testspersonalized oncology solutionsblood-based cancer screeningcancer genomics and liquid biopsybiotechnologyprecision medicine+10 more
30 total keywords

Guardant Health

Overview

Guardant Health is a biotechnology and precision oncology company based in Palo Alto, California, founded in 2011. The company specializes in developing liquid biopsy tests that detect cancer-related genomic alterations from blood samples, providing a non-invasive alternative to traditional tissue biopsies.

Key products include Guardant360™, a blood test that analyzes cancer genomics to inform treatment decisions for advanced cancer patients. Other offerings, such as GuardantOMNI, GuardantINFINITY, and GuardantINFORM, support early cancer detection and monitor disease progression. Additionally, the company is developing a blood-based cancer screening test focused on colorectal cancer, aimed at enabling routine screening through simple blood draws. The organization collaborates with biopharmaceutical firms to accelerate drug development and maintains a robust intellectual property portfolio with numerous patents in liquid biopsy technology. Guardant Health went public in 2018, reflecting a multidisciplinary approach to advancing cancer diagnostics and treatment.

Basic Information

Industry research
Founded 2011
Revenue $739M
Headquarters 3100 Hanover St, Palo Alto, California, 94304-1119, United States
Languages English
Alexa Ranking

Contact Details

Key Focus Areas & Initiatives

  • Health & wellness
  • Medical specialties
  • Biotechnology research
  • Early detection
  • Pharmaceuticals
  • Cancer treatment response monitoring
  • Healthcare
  • Cancer recurrence detection
  • Molecular profiling
  • Clinical oncology
  • Circulating tumor DNA diagnostics
  • Cancer management
  • Cancer treatment personalization
  • FDA-approved tests
  • Personalized oncology solutions
  • Blood-based cancer screening
  • Cancer genomics and liquid biopsy
  • Precision medicine
  • Advanced cancer diagnostics
  • Biopharmaceutical collaborations
  • Liquid biopsy technology
  • Oncology diagnostics
  • Non-invasive diagnostics
  • Clinical trials
  • Genomic testing
  • Personalized cancer care
  • Oncology innovation

Technologies Used

  • Adobe Media Optimizer
  • Amazon AWS
  • Apache
  • Atlassian Cloud
  • BugHerd
  • Cedexis Radar
  • Drupal
  • Facebook Conversion Tracking
  • Google Analytics
  • Google Font API
  • Google Tag Manager
  • Gravity Forms
  • Linkedin Marketing Solutions
  • Mobile Friendly
  • Oracle Cloud
  • Outlook
  • Pardot
  • React
  • React Redux
  • Remote
  • Route 53
  • ShareThis
  • SmartRecruiters
  • Twitter Advertising
  • Vimeo
  • WordPress.org
  • YouTube
  • reCAPTCHA

Affiliated Organizations & Regional Branches

Need more information?

Find decision makers, more insights and contact information about this company on Bitscale

Start For Free

Schedule your demo now!

See how BitScale can supercharge your outbound sales in a 30-minute demo

Start for Free
SayData

© 2026 Bitscale. Featherflow Technology Pvt Ltd

LinkedInTwitterInstagramYouTube